Upload
mohammad-sutami
View
16
Download
0
Embed Size (px)
DESCRIPTION
kuliah kedokteran ulkus peptikum fkumm
Citation preview
7/18/2019 kuliah ulkus peptikum
http://slidepdf.com/reader/full/kuliah-ulkus-peptikum 1/14
Peptic Ulcer Disease
Dr. Isbandiyah, SpPD
7/18/2019 kuliah ulkus peptikum
http://slidepdf.com/reader/full/kuliah-ulkus-peptikum 2/14
A peptic ulcer is a mucosalbreak, 3 mm or greater, thatcan involve the stomach or
duodenum
Definition
7/18/2019 kuliah ulkus peptikum
http://slidepdf.com/reader/full/kuliah-ulkus-peptikum 3/14
Peptic Ulcers:astric ! Dudodenal
7/18/2019 kuliah ulkus peptikum
http://slidepdf.com/reader/full/kuliah-ulkus-peptikum 4/14
"tiology
• #he most important contributing $actors are H pylori, %SAIDs, acid, and pepsin.
• Additional aggressive $actors include smoking,ethanol, bile acids, aspirin, steroids, and stress.
• Important protective $actors are mucus,bicarbonate, mucosal blood &o',prostaglandins, hydrophobic layer, andepithelial rene'al.
– Increased risk 'hen older than () d*t decreaseprotection
• +hen an imbalance occurs, PUD might develop.
7/18/2019 kuliah ulkus peptikum
http://slidepdf.com/reader/full/kuliah-ulkus-peptikum 5/14
Pathogenesis of Ulcers
Aggressive Factors Acid, pepsin Bile salts Drugs (NSAIDs) H. pylori
Defensive Factors Mucus, bicarbonate layer Blood flow, cell renewal Prostaglandins Phospholipid Free radical scavengers
Therapy is directed at enhancing host defense oreliminating aggressive factors; i.e., H. pylori.
7/18/2019 kuliah ulkus peptikum
http://slidepdf.com/reader/full/kuliah-ulkus-peptikum 6/14
Subective Data
• Pain-gna'ing, /aching, or /burning – Duodenal ulcers: occurs 013 hours a$ter a meal and
may a'aken patient $rom sleep. Pain is relieved by$ood, antacids, or vomiting.
– astric ulcers: $ood may e2acerbate the pain 'hilevomiting relieves it.
• %ausea, vomiting, belching, dyspepsia,bloating, chest discom$ort, anore2ia,hematemesis, !*or melena may also occur. – nausea, vomiting, ! 'eight loss more common 'ith
astric ulcers
7/18/2019 kuliah ulkus peptikum
http://slidepdf.com/reader/full/kuliah-ulkus-peptikum 7/14
bective Data
• "pigastric tenderness
• uaic1positive stool resulting $rom occult blood loss
• Succussion splash resulting $rom scaring or edemadue to partial or complete gastric outlet obstruction – A succussion splash describes the sound obtained by
shaking an individual 'ho has $ree &uid and air or gas in ahollo' organ or body cavity.
– Usually elicited to con4rm intestinal or pyloric obstruction.
– Done by gently shaking the abdomen by holding either
side o$ the pelvis. A positive test occurs 'hen a splashingnoise is heard, either 'ith or 'ithout a stethoscope. It isnot valid i$ the pt has eaten or drunk &uid 'ithin the lastthree hours.
7/18/2019 kuliah ulkus peptikum
http://slidepdf.com/reader/full/kuliah-ulkus-peptikum 8/14
Diagnostic Plan
• Stool $or $ecal occult blood
• 5abs: 676 89* bleeding, liver $unction test,amylase, and lipase.
• ;. Pylori can be diagnosed by urea breath test,blood test, stool antigen assays, ! rapid ureasetest on a biopsy sample.
• Upper I "ndoscopy: Any pt <() yo 'ith ne'
onset o$ symptoms or those 'ith alarmmarkings including anemia, 'eight loss, or Ibleeding.
7/18/2019 kuliah ulkus peptikum
http://slidepdf.com/reader/full/kuliah-ulkus-peptikum 9/14
#reatment Plan: ;. Pylori
• =edications: #riple therapy $or 0> days is considered thetreatment o$ choice. – Proton Pump Inhibitor ? clarithromycin and amo2icillin
• mepra@ole 8Prilosec: ) mg P bid $or 0> d or5ansopra@ole 8Prevacid: 3) mg P bid $or 0> d or
9abepra@ole 8Aciphe2: ) mg P bid $or 0> d or"somepra@ole 8%e2ium: >) mg P Bd $or 0> d plus6larithromycin 87ia2in: ()) mg P bid $or 0> andAmo2icillin 8Amo2il: 0 g P bid $or 0> d
• 6an substitute Clagyl ()) mg P bid $or 0> d i$ allergic
– In the setting o$ an active ulcer, continue Bd protonpump inhibitor therapy $or additional 'eeks.
• oal: complete elimination o$ ;. Pylori. nce achievedrein$ection rates are lo'. 6ompliance
7/18/2019 kuliah ulkus peptikum
http://slidepdf.com/reader/full/kuliah-ulkus-peptikum 10/14
#reatment Plan: %ot ;.Pylori
• =edications-treat 'ith Proton PumpInhibitors or ; receptor antagoniststo assist ulcer healing
– ;: #agament, Pepcid, A2id, or Eantac$or up to F 'eeks
– PPI: Prilosec, Prevacid, %e2ium, Protoni2,
or Aciphe2 $or >1F 'eeks.
7/18/2019 kuliah ulkus peptikum
http://slidepdf.com/reader/full/kuliah-ulkus-peptikum 11/14
5i$estyle 6hanges
• Discontinue %SAIDs and use Acetaminophen$or pain control i$ possible.
• Acid suppression11Antacids
•Smoking cessation
• %o dietary restrictions unless certain $oodsare associated 'ith problems.
• Alcohol in moderation –
=en under G(: drinks*day – =en over G( and all 'omen: 0 drink*day
• Stress reduction
7/18/2019 kuliah ulkus peptikum
http://slidepdf.com/reader/full/kuliah-ulkus-peptikum 12/14
6omplications
• Per$oration ! Penetration-intopancreas, liver and retroperitoneal space
• Peritonitis
• 7o'el obstruction, astric out&o'obstruction, ! Pyloric stenosis
• 7leeding11occurs in (H to 33H o$ cases
and accounts $or (H o$ ulcer deaths.• astric 6A
7/18/2019 kuliah ulkus peptikum
http://slidepdf.com/reader/full/kuliah-ulkus-peptikum 13/14
Surgery
• People 'ho do not respond to medication, or'ho develop complications: – agotomy 1 cutting the vagus nerve to interrupt
messages sent $rom the brain to the stomach to
reducing acid secretion. – Antrectomy 1 remove the lo'er part o$ the stomach
8antrum, 'hich produces a hormone that stimulatesthe stomach to secrete digestive uices. A vagotomyis usually done in conunction 'ith an antrectomy.
– Pyloroplasty 1 the opening into the duodenum andsmall intestine 8pylorus are enlarged, enablingcontents to pass more $reely $rom the stomach. =aybe per$ormed along 'ith a vagotomy.
7/18/2019 kuliah ulkus peptikum
http://slidepdf.com/reader/full/kuliah-ulkus-peptikum 14/14
"valuation*Collo'1up*9e$errals
• ;. Pylori Positive: retesting $or t2 eJcacy• Urea breath test-no sooner than > 'eeks a$ter
therapy to avoid $alse negative results
• Stool antigen test-an F 'eek interval must be
allo'ed a$ter therapy.
• ;. Pylori %egative: evaluate symptomsa$ter one month. Patients 'ho arecontrolled should cont. 1> more 'eeks.
• I$ symptoms persist then re$er tospecialist $or additional diagnostictesting.